Prevalence of exocrine pancreatic insufficiency in type 2 diabetes mellitus with poor glycemic control

Viktória Terzin, Tamás Várkonyi, Annamária Szabolcs, Csaba Lengyel, Tamás Takács, Gábor Zsóri, Anette Stájer, András Palkó, Tibor Wittmann, Attila Pálinkás, László Czakó

Research output: Contribution to journalArticle

18 Citations (Scopus)


Objectives To evaluate the relationship between exocrine pancreatic insufficiency and the level of glycemic control in diabetes (DM). Methods Patients with type 2 DM treated in our clinic were prospectively recruited into the study. Pancreatic diabetes was excluded. Cases with HbA1c ≥7% formed Group A (n = 59), and with HbA1c <7% Group B (n = 42). The fecal level of pancreatic elastase (PE-1) was measured and morphological examinations of the pancreas were performed. Results The PE-1 level was significantly lower in Group A than in Group B (385.9 ± 171.1 μg/g, vs. 454.6 ± 147.3 μg/g, p = 0.038). The PE-1 level was not correlated with HbA1c (r = -0.132, p = 0.187), the duration of DM (r = -0.046, p = 0.65), age (r = 0.010, p = 0.921), BMI (r = 0.203, p = 0.059), or pancreatic steatosis (r = 0.117, p = 0.244). The size of the pancreas did not differ significantly between Groups A and B. Conclusions An exocrine pancreatic insufficiency demonstrated by fecal PE-1 determination is more frequent in type 2 DM patients with poor glycemic control. The impaired exocrine pancreatic function cannot be explained by an alteration in the size of the pancreas or by pancreatic steatosis.

Original languageEnglish
Pages (from-to)356-360
Number of pages5
Issue number5
Publication statusPublished - Sep 1 2014


  • Chronic pancreatitis
  • Diabetes mellitus
  • Exocrine pancreatic insufficiency
  • Fecal elastase 1
  • Glycemic control
  • Pancreatic enzyme replacement

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Prevalence of exocrine pancreatic insufficiency in type 2 diabetes mellitus with poor glycemic control'. Together they form a unique fingerprint.

  • Cite this